Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
Comparison Results
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
HK$5.19
HK$17.24B
19.65
19.91%
―
HUTCHMED (China)
HK$21.18
HK$20.52B
4.97
12.27%
10 Buy
0 Hold
1 Sell
Strong Buy
Shanghai Fosun Pharmaceutical (Group) Co
HK$19.63
HK$75.27B
14.15
46.55%
2 Buy
0 Hold
0 Sell
Moderate Buy
China Resources Pharmaceutical Group Ltd.
HK$4.61
HK$39.83B
6.37
28.08%
5 Buy
0 Hold
0 Sell
Strong Buy
Performance Comparison
HK:9989
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
5.06
0.88
21.05%
HK:0013
HUTCHMED (China)
23.52
0.52
2.26%
HK:2196
Shanghai Fosun Pharmaceutical (Group) Co
19.96
6.13
44.33%
HK:3320
China Resources Pharmaceutical Group Ltd.
6.34
1.46
29.79%
HK:1558
―
―
―
―
HK:6185
CanSino Biologics, Inc. Class H
32.74
2.49
8.23%